Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, USA.
Cell Cycle. 2010 Dec 1;9(23):4735-47. doi: 10.4161/cc.9.23.14091.
Studies in budding yeast suggest the protein kinase Rad53 plays novel roles in controlling initiation of DNA replication and in maintaining cellular histone levels, and these roles are independent of Rad53-mediated regulation of the checkpoint and of nucleotide levels. In order to elucidate the role of Rad53 in replication initiation, we isolated a novel allele of RAD53, rad53-rep, that separates the checkpoint function of RAD53 from the DNA replication function. rad53-rep mutants display a chromosome loss phenotype that is suppressed by increased origin dosage, providing further evidence that Rad53 plays a role in the initiation of DNA replication. Deletion of the major histone H3-H4 pair suppresses rad53-rep-cdc7-1 synthetic lethality, suggesting Rad53's functions in degradation of excess cellular histone and in replication initiation are related. Rad53-rep is active as a protein kinase yet fails to interact with origins of replication and like the rad53D mutant, the rad53-rep mutant accumulates excess soluble histones, and it is sensitive to histone dosage. In contrast, a checkpoint defective allele of RAD53 with mutations in both FHA domains, binds origins, and growth of a rad53-FHA mutant is unaffected by histone dosage. Based on these observations, we hypothesize that the origin binding and the histone degradation activities of Rad53 are central to its function in DNA replication and are independent of its checkpoint functions. We propose a model in which Rad53 acts as a "nucleosome buffer," interacting with origins of replication to prevent the binding of excess histones to origin DNA and to maintain proper chromatin configuration.
在芽殖酵母中的研究表明蛋白激酶 Rad53 在控制 DNA 复制起始和维持细胞组蛋白水平方面发挥了新的作用,这些作用独立于 Rad53 介导的检查点和核苷酸水平的调节。为了阐明 Rad53 在复制起始中的作用,我们分离出了 RAD53 的一个新等位基因 rad53-rep,它将 RAD53 的检查点功能与 DNA 复制功能分开。rad53-rep 突变体表现出染色体丢失表型,这种表型可以被增加起始点的剂量所抑制,这进一步证明了 Rad53 在 DNA 复制起始中发挥作用。主要组蛋白 H3-H4 对的缺失抑制了 rad53-rep-cdc7-1 的合成致死性,表明 Rad53 在降解多余细胞组蛋白和复制起始中的功能有关。rad53-rep 作为蛋白激酶具有活性,但不能与复制起点相互作用,并且与 rad53D 突变体一样,rad53-rep 突变体积累了过多的可溶性组蛋白,并且对组蛋白剂量敏感。相比之下,RAD53 的一个检查点缺陷等位基因,其 FHA 结构域都发生了突变,与复制起点结合,并且 rad53-FHA 突变体的生长不受组蛋白剂量的影响。基于这些观察结果,我们假设 Rad53 的原点结合和组蛋白降解活性是其在 DNA 复制中功能的核心,并且独立于其检查点功能。我们提出了一个模型,其中 Rad53 充当“核小体缓冲液”,与复制起点相互作用,以防止多余的组蛋白与起点 DNA 结合,并维持适当的染色质构象。